CpG methylation recruits sequence specific transcription factors essential for tissue specific gene expression

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1819, Issue 7, 2012, Pages 763-770

  Chatterjee, Raghunath ^a   Vinson, Charles ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

5 azacytidine; Cancer; CpG island; DNA methylation; Epigenetics; Transcription

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; AMINO ACID; AZACITIDINE; DEXAMETHASONE; INSULIN; ISOBUTYLMETHYLXANTHINE; ROSIGLITAZONE; TRANSCRIPTION FACTOR;

ACUTE LEUKEMIA; ADIPOCYTE; AMINO ACID SEQUENCE; CARCINOGENESIS; CELL DIFFERENTIATION; COLORECTAL CANCER; CPG ISLAND; CPG ISLAND METHYLATION; DNA METHYLATION; DNA TRANSCRIPTION; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; GENE BODY METHYLATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE STRUCTURE; GENOME IMPRINTING; HUMAN; METHYLATION; MYELODYSPLASTIC SYNDROME; NEPHROBLASTOMA; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SOMATIC MUTATION;

ANIMALS; CELL DIFFERENTIATION; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOME, HUMAN; HUMANS; NEOPLASMS; NUCLEOSOMES; ORGAN SPECIFICITY; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

ANIMALIA; MAMMALIA;

EID: 84861839326     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2012.02.014     Document Type: Review

References (100)

1. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002, 16:6-21.
2. Lister R., O'Malley R.C., Tonti-Filippini J., Gregory B.D., Berry C.C., Millar A.H., Ecker J.R. Highly integrated single-base resolution maps of the epigenome in Arabidopsis. Cell 2008, 133:523-536.
3. Lister R., Pelizzola M., Dowen R.H., Hawkins R.D., Hon G., Tonti-Filippini J., Nery J.R., Lee L., Ye Z., Ngo Q.M., Edsall L., Antosiewicz-Bourget J., Stewart R., Ruotti V., Millar A.H., Thomson J.A., Ren B., Ecker J.R. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009, 462:315-322.
4. Bird A.P. DNA methylation and the frequency of CpG in animal DNA. Nucleic Acids Res. 1980, 8:1499-1504.
5. Illingworth R.S., Bird A.P. CpG islands-'a rough guide'. FEBS Lett. 2009, 583:1713-1720.
6. Gardiner-Garden M., Frommer M. CpG islands in vertebrate genomes. J. Mol. Biol. 1987, 196:261-282.
7. Takai D., Jones P.A. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:3740-3745.
8. Illingworth R., Kerr A., Desousa D., Jorgensen H., Ellis P., Stalker J., Jackson D., Clee C., Plumb R., Rogers J., Humphray S., Cox T., Langford C., Bird A. A novel CpG island set identifies tissue-specific methylation at developmental gene loci. PLoS Biol. 2008, 6:e22.
9. Illingworth R.S., Gruenewald-Schneider U., Webb S., Kerr A.R., James K.D., Turner D.J., Smith C., Harrison D.J., Andrews R., Bird A.P. Orphan CpG islands identify numerous conserved promoters in the mammalian genome. PLoS Genet. 2010, 6.
10. Deaton A.M., Bird A. CpG islands and the regulation of transcription. Genes Dev. 2011, 25:1010-1022.
11. Weber M., Hellmann I., Stadler M.B., Ramos L., Paabo S., Rebhan M., Schubeler D. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet. 2007, 39:457-466.
12. Saxonov S., Berg P., Brutlag D.L. A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:1412-1417.
13. Eckhardt F., Lewin J., Cortese R., Rakyan V.K., Attwood J., Burger M., Burton J., Cox T.V., Davies R., Down T.A., Haefliger C., Horton R., Howe K., Jackson D.K., Kunde J., Koenig C., Liddle J., Niblett D., Otto T., Pettett R., Seemann S., Thompson C., West T., Rogers J., Olek A., Berlin K., Beck S. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat. Genet. 2006, 38:1378-1385.
14. Fouse S.D., Shen Y., Pellegrini M., Cole S., Meissner A., Van Neste L., Jaenisch R., Fan G. Promoter CpG methylation contributes to ES cell gene regulation in parallel with Oct4/Nanog, PcG complex, and histone H3 K4/K27 trimethylation. Cell Stem Cell 2008, 2:160-169.
15. Hargreaves D.C., Horng T., Medzhitov R. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 2009, 138:129-145.
16. Rishi V., Bhattacharya P., Chatterjee R., Rozenberg J., Zhao J., Glass K., Fitzgerald P., Vinson C. CpG methylation of half-CRE sequences creates C/EBPalpha binding sites that activate some tissue-specific genes. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:20311-20316.
17. Jones P.A. The DNA methylation paradox. Trends Genet. 1999, 15:34-37.
18. Suzuki M.M., Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet. 2008, 9:465-476.
19. Zemach A., McDaniel I.E., Silva P., Zilberman D. Genome-wide evolutionary analysis of eukaryotic DNA methylation. Science 2010, 328:916-919.
20. Hellman A., Chess A. Gene body-specific methylation on the active X chromosome. Science 2007, 315:1141-1143.
21. Ball M.P., Li J.B., Gao Y., Lee J.H., LeProust E.M., Park I.H., Xie B., Daley G.Q., Church G.M. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat. Biotechnol. 2009, 27:361-368.
22. Hodges E., Smith A.D., Kendall J., Xuan Z., Ravi K., Rooks M., Zhang M.Q., Ye K., Bhattacharjee A., Brizuela L., McCombie W.R., Wigler M., Hannon G.J., Hicks J.B. High definition profiling of mammalian DNA methylation by array capture and single molecule bisulfite sequencing. Genome Res. 2009, 19:1593-1605.
23. Jeltsch A. Molecular biology. Phylogeny of methylomes. Science 2010, 328:837-838.
24. Shukla S., Kavak E., Gregory M., Imashimizu M., Shutinoski B., Kashlev M., Oberdoerffer P., Sandberg R., Oberdoerffer S. CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing. Nature 2011, 479:74-79.
25. Workman J.L., Kingston R.E. Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu. Rev. Biochem. 1998, 67:545-579.
26. Rando O.J. Global patterns of histone modifications. Curr. Opin. Genet. Dev. 2007, 17:94-99.
27. Kurdistani S.K., Tavazoie S., Grunstein M. Mapping global histone acetylation patterns to gene expression. Cell 2004, 117:721-733.
28. Heintzman N.D., Stuart R.K., Hon G., Fu Y., Ching C.W., Hawkins R.D., Barrera L.O., Van Calcar S., Qu C., Ching K.A., Wang W., Weng Z., Green R.D., Crawford G.E., Ren B. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 2007, 39:311-318.
29. Jiang C., Pugh B.F. Nucleosome positioning and gene regulation: advances through genomics. Nat. Rev. Genet. 2009, 10:161-172.
30. Kaplan N., Moore I.K., Fondufe-Mittendorf Y., Gossett A.J., Tillo D., Field Y., LeProust E.M., Hughes T.R., Lieb J.D., Widom J., Segal E. The DNA-encoded nucleosome organization of a eukaryotic genome. Nature 2009, 458:362-366.
31. Valouev A., Johnson S.M., Boyd S.D., Smith C.L., Fire A.Z., Sidow A. Determinants of nucleosome organization in primary human cells. Nature 2011, 474:516-520.
32. FitzGerald P.C., Sturgill D., Shyakhtenko A., Oliver B., Vinson C. Comparative genomics of Drosophila and human core promoters. Genome Biol. 2006, 7:R53.
33. Tillo D., Kaplan N., Moore I.K., Fondufe-Mittendorf Y., Gossett A.J., Field Y., Lieb J.D., Widom J., Segal E., Hughes T.R. High nucleosome occupancy is encoded at human regulatory sequences. PLoS One 2010, 5:e9129.
34. Davey C., Pennings S., Allan J. CpG methylation remodels chromatin structure in vitro. J. Mol. Biol. 1997, 267:276-288.
35. Chodavarapu R.K., Feng S., Bernatavichute Y.V., Chen P.Y., Stroud H., Yu Y., Hetzel J.A., Kuo F., Kim J., Cokus S.J., Casero D., Bernal M., Huijser P., Clark A.T., Kramer U., Merchant S.S., Zhang X., Jacobsen S.E., Pellegrini M. Relationship between nucleosome positioning and DNA methylation. Nature 2010, 466:388-392.
36. Fan Y., Nikitina T., Zhao J., Fleury T.J., Bhattacharyya R., Bouhassira E.E., Stein A., Woodcock C.L., Skoultchi A.I. Histone H1 depletion in mammals alters global chromatin structure but causes specific changes in gene regulation. Cell 2005, 123:1199-1212.
37. Schwartz S., Meshorer E., Ast G. Chromatin organization marks exon-intron structure. Nat. Struct. Mol. Biol. 2009, 16:990-995.
38. Ramirez-Carrozzi V.R., Braas D., Bhatt D.M., Cheng C.S., Hong C., Doty K.R., Black J.C., Hoffmann A., Carey M., Smale S.T. A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell 2009, 138:114-128.
39. Reik W., Dean W., Walter J. Epigenetic reprogramming in mammalian development. Science 2001, 293:1089-1093.
40. Rougier N., Bourc'his D., Gomes D.M., Niveleau A., Plachot M., Paldi A., Viegas-Pequignot E. Chromosome methylation patterns during mammalian preimplantation development. Genes Dev. 1998, 12:2108-2113.
41. Mayer W., Niveleau A., Walter J., Fundele R., Haaf T. Demethylation of the zygotic paternal genome. Nature 2000, 403:501-502.
42. Oswald J., Engemann S., Lane N., Mayer W., Olek A., Fundele R., Dean W., Reik W., Walter J. Active demethylation of the paternal genome in the mouse zygote. Curr. Biol. 2000, 10:475-478.
43. Carlson L.L., Page A.W., Bestor T.H. Properties and localization of DNA methyltransferase in preimplantation mouse embryos: implications for genomic imprinting. Genes Dev. 1992, 6:2536-2541.
44. Cardoso M.C., Leonhardt H. DNA methyltransferase is actively retained in the cytoplasm during early development. J. Cell Biol. 1999, 147:25-32.
45. Hajkova P., Ancelin K., Waldmann T., Lacoste N., Lange U.C., Cesari F., Lee C., Almouzni G., Schneider R., Surani M.A. Chromatin dynamics during epigenetic reprogramming in the mouse germ line. Nature 2008, 452:877-881.
46. Farthing C.R., Ficz G., Ng R.K., Chan C.F., Andrews S., Dean W., Hemberger M., Reik W. Global mapping of DNA methylation in mouse promoters reveals epigenetic reprogramming of pluripotency genes. PLoS Genet. 2008, 4:e1000116.
47. Straussman R., Nejman D., Roberts D., Steinfeld I., Blum B., Benvenisty N., Simon I., Yakhini Z., Cedar H. Developmental programming of CpG island methylation profiles in the human genome. Nat. Struct. Mol. Biol. 2009, 16:564-571.
48. Tsumura A., Hayakawa T., Kumaki Y., Takebayashi S., Sakaue M., Matsuoka C., Shimotohno K., Ishikawa F., Li E., Ueda H.R., Nakayama J., Okano M. Maintenance of self-renewal ability of mouse embryonic stem cells in the absence of DNA methyltransferases Dnmt1, Dnmt3a and Dnmt3b. Genes Cells 2006, 11:805-814.
49. Laurent L., Wong E., Li G., Huynh T., Tsirigos A., Ong C.T., Low H.M., Kin Sung K.W., Rigoutsos I., Loring J., Wei C.L. Dynamic changes in the human methylome during differentiation. Genome Res. 2010, 20:320-331.
50. Imamura M., Miura K., Iwabuchi K., Ichisaka T., Nakagawa M., Lee J., Kanatsu-Shinohara M., Shinohara T., Yamanaka S. Transcriptional repression and DNA hypermethylation of a small set of ES cell marker genes in male germline stem cells. BMC Dev. Biol. 2006, 6:34.
51. Feldman N., Gerson A., Fang J., Li E., Zhang Y., Shinkai Y., Cedar H., Bergman Y. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat. Cell Biol. 2006, 8:188-194.
52. Epsztejn-Litman S., Feldman N., Abu-Remaileh M., Shufaro Y., Gerson A., Ueda J., Deplus R., Fuks F., Shinkai Y., Cedar H., Bergman Y. De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat. Struct. Mol. Biol. 2008, 15:1176-1183.
53. Meissner A., Mikkelsen T.S., Gu H., Wernig M., Hanna J., Sivachenko A., Zhang X., Bernstein B.E., Nusbaum C., Jaffe D.B., Gnirke A., Jaenisch R., Lander E.S. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 2008, 454:766-770.
54. Takizawa T., Nakashima K., Namihira M., Ochiai W., Uemura A., Yanagisawa M., Fujita N., Nakao M., Taga T. DNA methylation is a critical cell-intrinsic determinant of astrocyte differentiation in the fetal brain. Dev. Cell 2001, 1:749-758.
55. Sen G.L., Reuter J.A., Webster D.E., Zhu L., Khavari P.A. DNMT1 maintains progenitor function in self-renewing somatic tissue. Nature 2010, 463:563-567.
56. Wyatt G.R., Cohen S.S. A new pyrimidine base from bacteriophage nucleic acids. Nature 1952, 170:1072-1073.
57. Kriaucionis S., Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 2009, 324:929-930.
58. Tahiliani M., Koh K.P., Shen Y., Pastor W.A., Bandukwala H., Brudno Y., Agarwal S., Iyer L.M., Liu D.R., Aravind L., Rao A. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324:930-935.
59. Guo J.U., Su Y., Zhong C., Ming G.L., Song H. Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 2011, 145:423-434.
60. Wu H., D'Alessio A.C., Ito S., Wang Z., Cui K., Zhao K., Sun Y.E., Zhang Y. Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. Genes Dev. 2011, 25:679-684.
61. Walsh C.P., Bestor T.H. Cytosine methylation and mammalian development. Genes Dev. 1999, 13:26-34.
62. Bird A.P. CpG-rich islands and the function of DNA methylation. Nature 1986, 321:209-213.
63. Bird A. The essentials of DNA methylation. Cell 1992, 70:5-8.
64. Vinokurova S., von Knebel Doeberitz M. Differential methylation of the HPV 16 upstream regulatory region during epithelial differentiation and neoplastic transformation. PLoS One 2011, 6:e24451.
65. Flower K., Thomas D., Heather J., Ramasubramanyan S., Jones S., Sinclair A.J. Epigenetic control of viral life-cycle by a DNA-methylation dependent transcription factor. PLoS One 2011, 6:e25922.
66. Feinberg A.P., Ohlsson R., Henikoff S. The epigenetic progenitor origin of human cancer. Nat. Rev. Genet. 2006, 7:21-33.
67. Jones P.A., Baylin S.B. The epigenomics of cancer. Cell 2007, 128:683-692.
68. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet. 2007, 8:286-298.
69. Esteller M. Epigenetics in cancer. N. Engl. J. Med. 2008, 358:1148-1159.
70. Rodriguez-Paredes M., Esteller M. Cancer epigenetics reaches mainstream oncology. Nat. Med. 2011, 17:330-339.
71. Baylin S.B., Jones P.A. A decade of exploring the cancer epigenome - biological and translational implications. Nat. Rev. Cancer 2011, 11:726-734.
72. Feinberg A.P., Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983, 301:89-92.
73. Cui H., Cruz-Correa M., Giardiello F.M., Hutcheon D.F., Kafonek D.R., Brandenburg S., Wu Y., He X., Powe N.R., Feinberg A.P. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 2003, 299:1753-1755.
74. Kaneda A., Feinberg A.P. Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor risk. Cancer Res. 2005, 65:11236-11240.
75. Ogawa O., Eccles M.R., Szeto J., McNoe L.A., Yun K., Maw M.A., Smith P.J., Reeve A.E. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 1993, 362:749-751.
76. Feinberg A.P. Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: an introduction. Cancer Res. 1999, 59:1743s-1746s.
77. Kim J.W., Dang C.V. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res. 2006, 66:8927-8930.
78. Chia N., Wang L., Lu X., Senut M.C., Brenner C., Ruden D.M. Hypothesis: environmental regulation of 5-hydroxymethylcytosine by oxidative stress. Epigenetics 2011, 6:853-856.
79. Liu X., Wang X., Zhang J., Lam E.K., Shin V.Y., Cheng A.S., Yu J., Chan F.K., Sung J.J., Jin H.C. Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis. Oncogene 2010, 29:442-450.
80. Ashburner B.P., Westerheide S.D., Baldwin A.S. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol. Cell. Biol. 2001, 21:7065-7077.
81. Bhat K.P., Pelloski C.E., Zhang Y., Kim S.H., deLaCruz C., Rehli M., Aldape K.D. Selective repression of YKL-40 by NF-kappaB in glioma cell lines involves recruitment of histone deacetylase-1 and -2. FEBS Lett. 2008, 582:3193-3200.
82. Robertson K.D., Ait-Si-Ali S., Yokochi T., Wade P.A., Jones P.L., Wolffe A.P. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat. Genet. 2000, 25:338-342.
83. Rountree M.R., Bachman K.E., Baylin S.B. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat. Genet. 2000, 25:269-277.
84. Fuks F., Burgers W.A., Brehm A., Hughes-Davies L., Kouzarides T. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat. Genet. 2000, 24:88-91.
85. Wang X., Jin H. The epigenetic basis of the Warburg effect. Epigenetics 2010, 5:566-568.
86. Akiyama Y., Watkins N., Suzuki H., Jair K.W., van Engeland M., Esteller M., Sakai H., Ren C.Y., Yuasa Y., Herman J.G., Baylin S.B. GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer. Mol. Cell. Biol. 2003, 23:8429-8439.
87. Lee W.H., Morton R.A., Epstein J.I., Brooks J.D., Campbell P.A., Bova G.S., Hsieh W.S., Isaacs W.B., Nelson W.G. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:11733-11737.
88. Walter M.J., Ding L., Shen D., Shao J., Grillot M., McLellan M., Fulton R., Schmidt H., Kalicki-Veizer J., O'Laughlin M., Kandoth C., Baty J., Westervelt P., DiPersio J.F., Mardis E.R., Wilson R.K., Ley T.J., Graubert T.A. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia 2011, 25:1153-1158.
89. Yan X.J., Xu J., Gu Z.H., Pan C.M., Lu G., Shen Y., Shi J.Y., Zhu Y.M., Tang L., Zhang X.W., Liang W.X., Mi J.Q., Song H.D., Li K.Q., Chen Z., Chen S.J. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat. Genet. 2011, 43:309-315.
90. Walter M.J., Ding L., Shen D., Shao J., Grillot M., McLellan M., Fulton R., Schmidt H., Kalicki-Veizer J., O'Laughlin M., Kandoth C., Baty J., Westervelt P., DiPersio J.F., Mardis E.R., Wilson R.K., Ley T.J., Graubert T.A. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia 2011, 25:1153-1158.
91. Langemeijer S.M., Kuiper R.P., Berends M., Knops R., Aslanyan M.G., Massop M., Stevens-Linders E., van Hoogen P., van Kessel A.G., Raymakers R.A., Kamping E.J., Verhoef G.E., Verburgh E., Hagemeijer A., Vandenberghe P., de Witte T., van der Reijden B.A., Jansen J.H. Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat. Genet. 2009, 41:838-842.
92. Langemeijer S.M., Jansen J.H., Hooijer J., van Hoogen P., Stevens-Linders E., Massop M., Waanders E., van Reijmersdal S.V., Stevens-Kroef M.J., Zwaan C.M., van den Heuvel-Eibrink M.M., Sonneveld E., Hoogerbrugge P.M., van Kessel A.G., Kuiper R.P. TET2 mutations in childhood leukemia. Leukemia 2011, 25:189-192.
93. Kanai Y., Ushijima S., Nakanishi Y., Sakamoto M., Hirohashi S. Mutation of the DNA methyltransferase (DNMT) 1 gene in human colorectal cancers. Cancer Lett. 2003, 192:75-82.
94. Figueroa M.E., Abdel-Wahab O., Lu C., Ward P.S., Patel J., Shih A., Li Y., Bhagwat N., Vasanthakumar A., Fernandez H.F., Tallman M.S., Sun Z., Wolniak K., Peeters J.K., Liu W., Choe S.E., Fantin V.R., Paietta E., Lowenberg B., Licht J.D., Godley L.A., Delwel R., Valk P.J., Thompson C.B., Levine R.L., Melnick A. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 2010, 18:553-567.
95. Ko M., Huang Y., Jankowska A.M., Pape U.J., Tahiliani M., Bandukwala H.S., An J., Lamperti E.D., Koh K.P., Ganetzky R., Liu X.S., Aravind L., Agarwal S., Maciejewski J.P., Rao A. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 2010, 468:839-843.
96. Prensner J.R., Chinnaiyan A.M. Metabolism unhinged: IDH mutations in cancer. Nat. Med. 2011, 17:291-293.
97. Issa J.P., Kantarjian H.M. Targeting DNA methylation. Clin. Cancer Res. 2009, 15:3938-3946.
98. Fenaux P., Mufti G.J., Hellstrom-Lindberg E., Santini V., Finelli C., Giagounidis A., Schoch R., Gattermann N., Sanz G., List A., Gore S.D., Seymour J.F., Bennett J.M., Byrd J., Backstrom J., Zimmerman L., McKenzie D., Beach C., Silverman L.R. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol. 2009, 10:223-232.
99. Vigil C.E., Martin-Santos T., Garcia-Manero G. Safety and efficacy of azacitidine in myelodysplastic syndromes. Drug Des. Devel. Ther. 2010, 4:221-229.
100. Garcia J.S., Jain N., Godley L.A. An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes. Onco Targets Ther. 2010, 3:1-13.